Saltar al contenido
Merck

Dyskinesia detection and monitoring by a single sensor in patients with Parkinson's disease.

Movement disorders : official journal of the Movement Disorder Society (2015-07-17)
Giovanna Lopane, Sabato Mellone, Lorenzo Chiari, Pietro Cortelli, Giovanna Calandra-Buonaura, Manuela Contin
RESUMEN

In current clinical practice, assessment of levodopa-induced dyskinesias (LIDs) in Parkinson's disease (PD) is based on semiquantitative scales or patients' diaries. We aimed to assess the feasibility, clinical validity, and usability of a waist-worn inertial sensor for discriminating between LIDs and physiological sway in both supervised and unsupervised settings. Forty-six PD patients on L-dopa therapy, 18 de novo PD patients, and 18 healthy controls were enrolled. Patients underwent clinical assessment of motor signs and dyskinesias and kinetic-dynamic L-dopa monitoring, tracked by serial measurements of plasma drug concentrations and motor and postural tests. A subset of features was selected, which showed excellent reliability. Sensitivity and specificity of the selected features for dyskinesia recognition were assessed in both supervised and unsupervised settings with an accuracy of 95% and 86%, respectively. Our preliminary findings suggest that it is feasible to design a reliable sensor-based application for dyskinesia monitoring at home.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Diisopropilamida de litio solution, 2.0 M in THF/heptane/ethylbenzene
Sigma-Aldrich
Diisopropilamida de litio solution, 1.0 M in THF/hexanes
Sigma-Aldrich
Lithium diisopropylamide, 97%